US regulation of plant-made biopharmaceuticals - Part 1

被引：0
|
作者：
Berberich, SA [1 ]
Devine, RA [1 ]
机构：
[1] Chloren Inc, Licensing & Dev, St Louis, MO 63141 USA
来源：
BIOPHARM INTERNATIONAL | 2005年 / 18卷 / 01期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
The evaluation, production, and distribution of therapeutic products derived from recombinant plants are regulated under existing laws administered by FDA, USDA, and EPA.
引用
收藏
页码：38 / +
页数：7
相关论文
共 50 条
  • [41] Research advances in plant-made flavivirus antigens
    Martinez, C. A.
    Giulietti, A. M.
    Rodriguez Talou, J.
    BIOTECHNOLOGY ADVANCES, 2012, 30 (06) : 1493 - 1505
  • [42] Current status of plant-made vaccines for veterinary purposes
    Ling, Huai-Yian
    Pelosi, Assunta
    Walmsley, Amanda M.
    EXPERT REVIEW OF VACCINES, 2010, 9 (08) : 971 - 982
  • [43] Fighting Ebola with ZMapp: spotlight on plant-made antibody
    ZHANG YunFang
    LI DaPeng
    JIN Xia
    HUANG Zhong
    Science China(Life Sciences), 2014, (10) : 987 - 988
  • [44] Oral immunogenicity of a plant-made, subunit, tuberculosis vaccine
    Rigano, MM
    Dreitz, S
    Kipnis, AP
    Izzo, AA
    Walmsley, AM
    VACCINE, 2006, 24 (05) : 691 - 695
  • [45] Plant-made vaccines and reagents for the One Health initiative
    Rybicki, Edward Peter
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (12) : 2912 - 2917
  • [46] Fighting Ebola with ZMapp: spotlight on plant-made antibody
    ZHANG YunFang
    LI DaPeng
    JIN Xia
    HUANG Zhong
    Science China(Life Sciences), 2014, 57 (10) : 987 - 988
  • [47] Implementation of Glycan Remodeling to Plant-Made Therapeutic Antibodies
    Bennett, Lindsay D.
    Yang, Qiang
    Berquist, Brian R.
    Giddens, John P.
    Ren, Zhongjie
    Kommineni, Vally
    Murray, Ryan P.
    White, Earl L.
    Holtz, Barry R.
    Wang, Lai-Xi
    Marcel, Sylvain
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (02)
  • [48] Development of plant-made monoclonal antibodies viral infections
    Chen, Qiang
    CURRENT OPINION IN VIROLOGY, 2022, 52 : 148 - 160
  • [49] Plant-made Vaccines and Therapeutics for COVID-19.
    Daniell, Henry
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2022, 58 (SUPPL 1) : S9 - S9
  • [50] An overview of tolerogenic immunotherapies based on plant-made antigens
    Govea-Alonso, Dania O.
    Arevalo-Villalobos, Jaime I.
    Marquez-Escobar, Veronica A.
    Vimolmangkang, Sornkanok
    Rosales-Mendoza, Sergio
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2019, 19 (06) : 587 - 599
12345